Page last updated: 2024-11-05

cme-carbodiimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

N,N'-Carbonyldiimidazole (CDI) is a commonly used reagent in organic synthesis for the activation of carboxylic acids. CDI reacts with carboxylic acids to form an activated intermediate, which can then be reacted with various nucleophiles, including alcohols, amines, and amides, to form esters, amides, and peptides, respectively. CDI is also used in the synthesis of cyclic imides, lactams, and other heterocyclic compounds. The reaction of CDI with carboxylic acids is typically carried out in a polar solvent, such as tetrahydrofuran (THF) or dichloromethane (DCM), at room temperature or slightly elevated temperatures. CDI is a highly reactive reagent and should be handled with care. CDI is a versatile reagent that has been used in the synthesis of a wide range of organic compounds, including pharmaceuticals, natural products, and polymers. The use of CDI in organic synthesis is well-established, and it is a valuable tool for the preparation of a wide variety of compounds. CDI is also studied for its ability to activate other functional groups, such as alcohols and amines, for subsequent reactions.'

Cross-References

ID SourceID
PubMed CID17220
CHEMBL ID1789981
SCHEMBL ID6533548
MeSH IDM0004653

Synonyms (50)

Synonym
NSC231596 ,
2491-17-0
n-cyclohexyl-n'-(2-(4-methyl-1,45-oxazinan-4-yl)ethyl)carbodiimide 4-methylbenzenesulfonate
n-cyclohexyl-n'-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate, >=97% (chn)
1-cyclohexyl 3-(2-morpholinoethyl)carbodiimide methotosylate
morpholinium, p-toluenesulfonate
n-cyclohexyl-n'-.beta.-(methylmorpholinium)ethylcarbodiimide p-toluenesulfonate
morpholinium, salt with 4-methylbenzenesulfonic acid (1:1)
cme-carbodiimide
n-cyclohexyl-n'-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate, >=99.0% (chn)
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate
n-cyclohexyl-n'-2-morpholinyl(4)ethylcarbodiimide methyl-p-toluenesulfonate
morpholinium, 4-(2-((cyclohexylimidocarbonyl)amino)ethyl)-4-methyl-, p-toluenesulfonate
nsc 231596
n-cyclohexyl-n'-(beta-(4-methylmorpholinio)ethyl)carbodiimide p-toluenesulfonate
4-(2-((cyclohexylcarbonimidoyl)amino)ethyl)-4-methylmorpholinium toluene-p-sulphonate
n-cyclohexyl-n'-beta-(4-methylmorpholinium)ethylcarbodiimide p-tolenesulfonate salt
einecs 219-650-3
chm (van)
morpholinium, 4-(2-((cyclohexylcarbonimidoyl)amino)ethyl)-4-methyl-, 4-methylbenzenesulfonate (1:1)
1-cyclohexyl-3-(2-morpholinyl-(4)-ethyl)carbodiimide metho-p-toluenesulfonate
n-cyclohexyl-n-(beta-(4-methylmorpholinium)ethyl)carbodiimide p-toluenesulfonate
cmc [n-cyclohexyl-n''-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate]
4-[2-[(cyclohexylcarbonimidoyl)amino]ethyl]-4-methylmorpholinium p-toluenesulfonate
FT-0607675
AKOS015903467
1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluenesulfonate
1-cyclohexyl-3-[2-(4-methylmorpholino)ethyl]carbodiimide p-toluenesulfonate
SCHEMBL6533548
CHEMBL1789981
n-cyclohexyl-n'-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate
n-cyclohexyl-n'-(2-morpholinoethyl)carbodiimide methyl-p-toluenesulfonate, 95%
mfcd00011979
J-015723
4-(2-(((cyclohexylimino)methylene)amino)ethyl)-4-methylmorpholin-4-ium 4-methylbenzenesulfonate
A877770
4-(2-((cyclohexylimino)methyleneamino)ethyl)-4-methylmorpholin-4-ium 4-methylbenzenesulfonate
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho p-toluene sulfonate
GBCAVSYHPPARHX-UHFFFAOYSA-M
1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho p-toluenesulfonate
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluene sulfonate
1cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate
AS-11083
D70774
DTXSID60907344
4-(2-{[(cyclohexylimino)methylidene]amino}ethyl)-4-methylmorpholin-4-ium 4-methylbenzene-1-sulfonate
102292-00-2
morpho-cdi
CS-W014457
1-cyclohexyl-3-[2-(4-methylmorpholino)ethyl]carbodiimidep-toluenesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (97)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (42.27)18.7374
1990's29 (29.90)18.2507
2000's13 (13.40)29.6817
2010's9 (9.28)24.3611
2020's5 (5.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.01%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other98 (98.99%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]